Kawasaki, Japan

Ryuta Takashita

This inventor holds 1 USPTO granted patent. Top assignee: Ea Pharma Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryuta Takashita. Retrieved from https://idiyas.com/inventor/ryuta-takashita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ryuta Takashita

Introduction

Ryuta Takashita is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on sulfonamide derivatives.

Latest Patents

Takashita holds a patent for a sulfonamide derivative and its medicinal use. This patent describes sulfonamide compounds characterized by a specific chemical structure, where a sulfonamide group is substituted with a phenyl group or a heterocyclic group containing hetero atoms. These novel compounds exhibit excellent α4 integrin-inhibitory action and include pharmaceutically acceptable salts.

Career Highlights

He is currently associated with Ea Pharma Co., Ltd., where he continues to advance his research and development efforts. His work has the potential to impact therapeutic approaches in various medical fields.

Collaborations

Takashita has collaborated with notable colleagues, including Hirokazu Ueno and Takashi Yamamoto, to further enhance the scope of his research and innovations.

Conclusion

Ryuta Takashita's contributions to medicinal chemistry through his patented innovations highlight the importance of research in developing new therapeutic agents. His work exemplifies the ongoing advancements in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…